Skip to main content

1 Result(s)

within Joleen M. Hubbard Remove this filter Cancer Research Remove this filter Gastroenterology Remove this filter Oncology Remove this filter

and

  1. No Access

    Article

    Progression-Free Survival in Patients Receiving Chemotherapy Alone (C) or Chemotherapy with Bevacizumab (CB) for First-Line Treatment of KRAS Mutant Metastatic Colorectal Cancer in Community Oncology Settings

    Bevacizumab is a standard first-line (L1) treatment for metastatic colorectal cancer (mCRC) patients regardless of RAS status. This retrospective study examined treatment patterns and outcomes in a community o...

    Arthur C. Houts, Sarika Ogale, Yousuf Zafar… in Journal of Gastrointestinal Cancer (2019)